We are live on
!
Find out more
NC
Naman Capital Portfolio holdings
AUM
$360M
1-Year Est. Return
27.43%
This Fund
S&P 500
This Quarter
Est. Return
+7.09%
1 Year Est. Return
+27.43%
3 Year Est. Return
+106.06%
5 Year Est. Return
+122.61%
10 Year Est. Return
–
AUM
$154M
AUM Growth
-$17.2M
(-10%)
Cap. Flow
-$17.3M
Cap. Flow
% of AUM
-11.27%
Top 10 Holdings %
Top 10 Hldgs %
82.06%
Holding
17
New
–
Increased
1
Reduced
4
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Ultrapar
UGP
|
+$2.98M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$7.26M |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$5.44M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$4.7M |
| 4 |
ProShares Short S&P500
SH
|
+$2.89M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Energy | 30% |
| 2 | Technology | 19.52% |
| 3 | Financials | 19.36% |
| 4 | Healthcare | 14.19% |
| 5 | Consumer Staples | 7.13% |
Similar funds
KLWA
LSC
5VM
RIP
WIP
NI
RA
SWM
Naman Capital's Q1 2022 Portfolio in Review
As of Q1 2022, Naman Capital held 17 positions worth $154M, down 10% from $171M the previous quarter. Its ten largest holdings account for 82% of the portfolio.
Naman Capital withdrew a net $17.3M in Q1 2022, reducing 4 holdings. Its largest reduction was Pfizer, cutting an estimated $7.26M.
By sector, the portfolio is most concentrated in Energy at 30% of assets, up from 24% a quarter earlier, followed by Technology and Financials.
Against the trend, Naman Capital added an estimated $2.98M to Ultrapar.
- Naman Capital added most to Ultrapar in Q1 2022, an estimated $2.98M increase.
- Naman Capital's biggest Q1 2022 reduction was Pfizer, cutting an estimated $7.26M.
- Naman Capital's ten largest holdings make up 82% of its $154M portfolio in Q1 2022.
- Naman Capital opened 0 new positions and closed 0 in Q1 2022.
- Naman Capital's portfolio value fell 10% quarter-over-quarter to $154M.
Based on Naman Capital's 13F filing for Q1 2022, filed 7 Oct 2022.